Glia, neurons, and neural progenitor cells all express TLR2 and TLR4, and may contribute to the striking responsiveness of several glioma models to metronomic CPA-induced anti-tumor immunity seen in our studies. This evidence concerns the gene TLR2 and neoplasm.